Pharmaceutical News and Articles

Higher Doses of Buprenorphine May Improve Treatment Outcomes for People with Opioid Use Disorder

Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent e

AbbVie Announces Positive Topline Results from Phase 3 TEMPO-1 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease

AbbVie (NYSE ABBV) today announced positive topline results from its pivotal Phase 3 TEMPO-1 trial for tavapadon as a monotherapy in early Parkinson s disease.

Eirion Therapeutics Announces Results of First-in-Human Clinical Trial Evaluating Ready-to-Use Liquid Injectable Neuromodulator AI-09 for the Treatment of Wrinkles

WOBURN, Mass., Oct. 1, 2024. Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings, an

FDA Grants Traditional Approval to Retevmo (selpercatinib) for Medullary Thyroid Cancer with a RET Mutation

2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck Cancer

The 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, acco

FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstr

AAP: Low Vitamin D Linked to Slower Fracture Healing in Pediatric Patients

For pediatric patients with lower-extremity fracture and surgical management, low vitamin D is associated with slower clinical and radiographic healing, accordi

Tolebrutinib Demonstrated a 31% Delay in Time to Onset of Confirmed Disability Progression in Non-Relapsing Secondary Progressive Multiple Sclerosis Phase 3 Study

Paris, September 20, 2024. Positive results from the HERCULES phase 3 study in people with non-relapsing secondary progressive multiple sclerosis (nrSPMS) demon

Dupixent Approved in the US as the First-Ever Biologic Medicine for Patients with COPD

Black, White Cancer Patients Now Benefit Equally From Cord Blood Therapy

Blood cancer patients of all races who receive cord blood transplants are now living longer. The finding, reported by a team led by oncologist Dr. Karen Ballen,